< Back

Christopher Marshallsay

BioNTech SE
Leader background:
is Head of Scientific/Medical Writing at BioNTech SE (Mainz, Germany). Christopher has over 20 years of experience in various roles in clinical development - including pharmacokinetics, medical writing, clinical trial disclosure, and as department/function head - whilst located in Aachen, Frankfurt, Mainz, and Paris. He has previously worked at Ciba-Geigy, Aventis, Sanofi, and Grünenthal. In his current role he manages a team providing integrated regulatory and publication writing services for research, non-clinical, and clinical teams, as well as providing clinical trial registration, status updating, and results reporting services. As a process nerd, Christopher is a key driver for process optimization and standardization at BioNTech. Christopher is also an experienced lecturer and workshop leader.
An Introduction to Clinical Trial Disclosure – the Regulatory Requirements, Industry Commitments, and Protection of Data Privacy and Company Confidential Information
    Level: Foundation Area: Drug Development
    Code: DDF36 Duration: 03:30:00
Publication of CSRs according to EMA Policy 0070 – Zurampic experience
    Level: Area:
    Code: Sym5.2 Duration: 00:30:00
Clinical Trial Registries and Public Databases - Gaining Efficiencies and Understanding Pitfalls
    Level: Area: Expert Seminar Series
    Code: ESS25 Duration:
An update on regulatory public disclosure - news, initiatives and changes to regulations
    Level: Area:
    Code: ESS32.4 Duration: 00:35:00